VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
EPHA2 is a mediator of vemurafenib resistance and a novel therapeutic target in melanoma
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
EPHA2 is a mediator of vemurafenib resistance and a novel therapeutic target in melanoma
EPHA2 is a mediator of vemurafenib resistance and a novel therapeutic target in melanoma. Cancer Discovery. 5:274-287.
authors with profiles
JENNIFER WARGO